255 related articles for article (PubMed ID: 27682863)
1. Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma.
Han KQ; Han H; He XQ; Wang L; Guo XD; Zhang XM; Chen J; Zhu QG; Nian H; Zhai XF; Jiang MW
Cancer Med; 2016 Oct; 5(10):2861-2871. PubMed ID: 27682863
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma.
Han KQ; He XQ; Ma MY; Guo XD; Zhang XM; Chen J; Han H; Zhang WW; Zhu QG; Nian H; Ma LJ
World J Gastroenterol; 2015 Apr; 21(16):4864-74. PubMed ID: 25944999
[TBL] [Abstract][Full Text] [Related]
3. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
4. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
[TBL] [Abstract][Full Text] [Related]
5. Targeted silencing of CXCL1 by siRNA inhibits tumor growth and apoptosis in hepatocellular carcinoma.
Han KQ; He XQ; Ma MY; Guo XD; Zhang XM; Chen J; Han H; Zhang WW; Zhu QG; Zhao WZ
Int J Oncol; 2015 Dec; 47(6):2131-40. PubMed ID: 26499374
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma.
Ding J; Xu K; Zhang J; Lin B; Wang Y; Yin S; Xie H; Zhou L; Zheng S
BMB Rep; 2018 Dec; 51(12):630-635. PubMed ID: 30293547
[TBL] [Abstract][Full Text] [Related]
7. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
8. Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation.
He Q; Huang W; Liu D; Zhang T; Wang Y; Ji X; Xie M; Sun M; Tian D; Liu M; Xia L
Theranostics; 2021; 11(12):5759-5777. PubMed ID: 33897880
[No Abstract] [Full Text] [Related]
9. The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu.
Nischalke HD; Lutz P; Bartok E; Krämer B; Langhans B; Frizler R; Berg T; Hampe J; Buch S; Datz C; Stickel F; Hartmann G; Strassburg CP; Nattermann J; Spengler U
J Mol Med (Berl); 2019 Nov; 97(11):1589-1600. PubMed ID: 31637480
[TBL] [Abstract][Full Text] [Related]
10. miR-589-5p inhibits MAP3K8 and suppresses CD90
Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
[TBL] [Abstract][Full Text] [Related]
11. Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a.
Cui X; Li Z; Gao J; Gao PJ; Ni YB; Zhu JY
Oncotarget; 2016 Oct; 7(40):65052-65066. PubMed ID: 27542259
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils.
Pan JJ; Xie SZ; Zheng X; Xu JF; Xu H; Yin RQ; Luo YL; Shen L; Chen ZR; Chen YR; Yu SZ; Lu L; Zhu WW; Lu M; Qin LX
Cancer Lett; 2024 Jun; 592():216903. PubMed ID: 38670307
[TBL] [Abstract][Full Text] [Related]
13. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
[TBL] [Abstract][Full Text] [Related]
15. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
16. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
17. Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells.
Kavandi L; Collier MA; Nguyen H; Syed V
J Cell Biochem; 2012 Oct; 113(10):3143-52. PubMed ID: 22615136
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and biophysical characterization of CXCL3 chemokine.
Gulati K; Gangele K; Agarwal N; Jamsandekar M; Kumar D; Poluri KM
Int J Biol Macromol; 2018 Feb; 107(Pt A):575-584. PubMed ID: 28928065
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus Infection Induces the Production of the Neutrophil Chemoattractants CXCL1, CXCL2, CXCL3, CXCL5, CCL3, and CCL7 by Murine Osteoblasts.
Sipprell SE; Johnson MB; Leach W; Suptela SR; Marriott I
Infect Immun; 2023 Apr; 91(4):e0001423. PubMed ID: 36880752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
